Terms: = Ovarian cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Diagnosis
51 results:
1. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
[TBL] [Abstract] [Full Text] [Related]
2. Metastasis from follicular lymphoma to an ovarian mature teratoma: a case report of tumor-to-tumor metastasis.
Sato Y; Yano M; Eto S; Takano K; Nasu K
J Ovarian Res; 2023 May; 16(1):106. PubMed ID: 37254134
[TBL] [Abstract] [Full Text] [Related]
3. A histopathological and immunohistochemistry analysis of endometrial lesions among women presenting with abnormal uterine bleeding.
Walvir NM; Rana S; Jairajpuri ZS; Jetley S; Nigam A
J Cancer Res Ther; 2022; 18(6):1474-1484. PubMed ID: 36412397
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-Suppressor Gene Transmembrane Protein 98 Promotes Proliferation and Inhibits Apoptosis in ovarian cancer.
Wu SG; Xu JY; Lei J; Hu M; Zhou J
Front Biosci (Landmark Ed); 2022 Jun; 27(7):210. PubMed ID: 35866395
[TBL] [Abstract] [Full Text] [Related]
5. ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway.
Ma C; Liu M; Zhang J; Cai H; Wu Y; Zhang Y; Ji Y; Shan H; Zou Z; Yang L; Liu L; Xu H; Lei H; Liu C; Zhou L; Cao Y; Zhou H; Wu Y
Chem Biol Interact; 2022 Jan; 351():109770. PubMed ID: 34861246
[TBL] [Abstract] [Full Text] [Related]
6. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological characteristics and genetic variations of uterine tumours resembling ovarian sex cord tumours.
Ye S; Wu J; Yao L; He J
J Clin Pathol; 2022 Nov; 75(11):776-781. PubMed ID: 34348985
[TBL] [Abstract] [Full Text] [Related]
8. The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
Wambecke A; Ahmad M; Morice PM; Lambert B; Weiswald LB; Vernon M; Vigneron N; Abeilard E; Brotin E; Figeac M; Gauduchon P; Poulain L; Denoyelle C; Meryet-Figuiere M
Mol Oncol; 2021 Dec; 15(12):3659-3678. PubMed ID: 34160887
[TBL] [Abstract] [Full Text] [Related]
9. Umbilical metastases: Real-world data shows abysmal outcome.
Hugen N; Kanne H; Simmer F; van de Water C; Voorham QJ; Ho VK; Lemmens VE; Simons M; Nagtegaal ID
Int J Cancer; 2021 Sep; 149(6):1266-1273. PubMed ID: 33990961
[TBL] [Abstract] [Full Text] [Related]
10. The mechanism of anticancer activity of the new synthesized compound - 6,7-Methylenedioxy-4-(2,4-dimethoxyphenyl)quinolin -2(1H)-one(12e) in human ovarian cancer cell lines.
Chan HC; Liao YH; Chang HW; Liu CH
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):266-272. PubMed ID: 33678326
[TBL] [Abstract] [Full Text] [Related]
11. New Diterpene Compound from
Abdolmohammadi MH; Fallahian F; Ghanadian M; Mirjani A; Aghaei M
Nutr Cancer; 2021; 73(10):2030-2038. PubMed ID: 32933316
[TBL] [Abstract] [Full Text] [Related]
12. The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.
Sun J; Cui XW; Li YS; Wang SY; Yin Q; Wang XN; Gu L
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7276-7283. PubMed ID: 32706065
[TBL] [Abstract] [Full Text] [Related]
13. Inhibitory effects of brusatol delivered using glycosaminoglycan‑placental chondroitin sulfate A‑modified nanoparticles on the proliferation, migration and invasion of cancer cells.
Chen X; Yin T; Zhang B; Sun B; Chen J; Xiao T; Wang B; Li M; Yang J; Fan X
Int J Mol Med; 2020 Aug; 46(2):817-827. PubMed ID: 32626948
[TBL] [Abstract] [Full Text] [Related]
14. TTDA inhibited apoptosis by regulating the p53-Bax/bcl2 axis in glioma.
Bai HL; Kang CM; Sun ZQ; Li XH; Dai XY; Huang RY; Zhao JJ; Bei YR; Huang XZ; Lu ZF; Wu SG; Lu JB; Ping BH; Wang Q; Hu YW
Exp Neurol; 2020 Sep; 331():113380. PubMed ID: 32540359
[TBL] [Abstract] [Full Text] [Related]
15. The influence of polypharmacy, potentially inappropriate medications, and drug interactions on treatment completion and prognosis in older patients with ovarian cancer.
Jørgensen TL; Herrstedt J;
J Geriatr Oncol; 2020 May; 11(4):593-602. PubMed ID: 31883969
[TBL] [Abstract] [Full Text] [Related]
16. MORPHOPHENOTYPIC CHARACTERISTICS OF ovarian SEROUS BORDERLINE TUMORS.
Munjishvili V; Barabadze E; Musashvili T; Gachechiladze M; Burkadze G
Georgian Med News; 2019 May; (290):20-25. PubMed ID: 31322508
[TBL] [Abstract] [Full Text] [Related]
17. Pericytoma With t(7;12): The First ovarian Case Reported and a Review of the Literature.
Koh NWC; Seow WY; Lee YT; Lam JCM; Lian DWQ
Int J Gynecol Pathol; 2019 Sep; 38(5):479-484. PubMed ID: 30085941
[TBL] [Abstract] [Full Text] [Related]
18. Current treatment of double hit and double expressor lymphoma.
Reagan PM; Davies A
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):295-297. PubMed ID: 29222269
[TBL] [Abstract] [Full Text] [Related]
19. Alternative tumor markers in the diagnosis of ovarian cancer.
Karakaya BK; Başer E; Bildacı B; Cömert EÇ; Bayraktar N; Dursun P; Kuşçu E; Ayhan A
Ginekol Pol; 2016; 87(8):565-769. PubMed ID: 27629130
[TBL] [Abstract] [Full Text] [Related]
20. Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.
Yuan W; Zhang Z; Dai B; Wei Q; Liu J; Liu Y; Liu Y; He L; Zhou D
Cancer; 2016 Jun; 122(11):1689-96. PubMed ID: 26998897
[TBL] [Abstract] [Full Text] [Related]
[Next]
